Codexis (CDXS) Expected to Announce Quarterly Earnings on Thursday

Codexis (NASDAQ:CDXS) is anticipated to post its quarterly earnings results after the market closes on Thursday, February 27th. Analysts expect Codexis to post earnings of ($0.04) per share and revenue of $27.41 million for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Codexis Stock Down 2.2 %

Shares of Codexis stock opened at $4.02 on Wednesday. The stock’s 50-day moving average is $4.65 and its 200 day moving average is $3.95. The firm has a market cap of $327.22 million, a price-to-earnings ratio of -4.62 and a beta of 2.12. The company has a debt-to-equity ratio of 0.39, a current ratio of 3.21 and a quick ratio of 3.15. Codexis has a one year low of $2.56 and a one year high of $6.08.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. Benchmark restated a “hold” rating on shares of Codexis in a report on Monday, November 4th. Cantor Fitzgerald reissued an “overweight” rating and issued a $11.00 target price on shares of Codexis in a research report on Friday, November 22nd.

Codexis Company Profile

Codexis, Inc discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes.